Novartis aims to nearly triple biosimilar drugs on market by 2020 - Reuters

Reuters

Novartis aims to nearly triple biosimilar drugs on market by 2020 Reuters KUFSTEIN, Austria Switzerland's Novartis pledged to nearly triple its number of biosimilar drugs on the market by 2020, raising its bet that cheaper versions of blockbuster cancer and immune system medicines will snatch billions in rivals' profits ... and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGCBOlqnKLsX-c9j4iDQxwAk9sefQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779135818678&ei=EkZnV_CeL4vapweBq6q4AQ&url=http://www.reuters.com/article/us-novartis-biosimilars-idUSKCN0Z50VH
via IFTTT